MYD88 and chronic kidney disease: PCA suppressed the molecular activity of TLR4 and MyD88 in the skeletal muscle of CKD rats and LPS‐induced C2C12 myoblasts, thereby preventing the phosphorylation of downstream NF‐κB p65.